FGEN Total Utang marang Modal FibroGen Corporation

Lambang korporat lan logo FibroGen, Inc. (FGEN)

FibroGen, Inc. (FGEN) attracts leading biologists through innovative developments in oncology and anemia, as confirmed by the daily price chart on GURU.Markets, where the indicator stands at 0.00. The business relies on global partnerships, yet remains vulnerable to trade restrictions and raw material logistics disruptions. The current position is further complicated by a loss of market influence and a dependence on payments from Asia.

FGEN: Total Utang marang Modal FibroGen 04.07.2022 - 08.01.2026
Produk merek FibroGen Corporation

This ratio determines the financing structure by comparing total liabilities to equity to assess the degree of credit risk and the business's financial autonomy. By analyzing the debt-to-equity trend, an investor can see the balance between borrowed capital and the resources FibroGen, Inc. (FGEN) requires to develop innovative HIF-PH inhibitors and bring unique anemia therapies to market.

Pesaing wigati

Utang marang Ekuitas Haleon HLN|Utang Agregat marang Ekuitas Kenvue Inc|Verona Pharma Corp (VRNA) - Total Utang marang Modal|Rasio Kabeh Utang marang Dana Pribadi Jyong Bio (MENS)|Total Utang marang Modal LGND (Ligand Pharmaceuticals)|amneal.com - Total Utang marang Modal|Utang marang Ekuitas Perrigo (PRGO)|ALVO: Rasio Kabeh Utang marang Dana Pribadi|LQDA (Liquidia Technologies) - Utang marang Ekuitas|Galapagos Corp (GLPG) - Rasio Total Utang marang Ekuitas|ANIP (ANI Pharmaceuticals) - Total Utang marang Modal|Total Utang marang Modal mannkindcorp.com (MNKD)|Amphastar Pharmaceuticals, Inc. (AMPH) - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi PCRX (Pacira Pharmaceuticals)|SPRY: Utang marang Ekuitas|TBPH - Utang marang Modal|Rasio Total Utang marang Ekuitas Aquestive Therapeutics AQST|SCPH - Utang Agregat marang Modal|Total Utang marang Modal tectonictx.com TECX|Tonix Pharma (TNXP) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal SXTC (SXT Pharmaceuticals)|Utang marang Modal EPRX|BioHarvest Sciences (BHST) - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi invizyne.com (EXOZ)|Oramed Pharmaceuticals Inc. (ORMP) - Total Utang marang Modal|Utang Agregat marang Ekuitas Entera Bio Ltd ENTX|Total Utang marang Modal HYFT (MindWalk)|ABVC - Koefisien Total Utang marang Modal|Cumberland Pharmaceuticals (CPIX) - Total Utang marang Modal|QNTM (quantumbiopharma.com) - Utang marang Ekuitas|TELO - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi RANI|Synergy CHC Corp - Utang marang Ekuitas|Utang marang Modal rallybio.com (RLYB)|LEXX (Lexaria Bioscience Corp.) - Total Utang marang Modal|Rasio Utang marang Modal pulmatrix.com PULM|PTHL (Pheton) - Total Utang marang Modal|APM: Utang marang Modal|Utang marang Ekuitas Lyra Therapeutics, Inc|Rasio Utang marang Ekuitas Impact BioMedical, Inc.|TNFA - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi cbdMD Corp|PRFX (PainReform) - Total Utang marang Modal|Koefisien Total Utang marang Modal CYTO (altamiratherapeutics.com)|LIPO - Utang marang Ekuitas|Rasio Utang marang Ekuitas OptiNose Corp OPTN|PIRS: Total Utang marang Modal|procapsgroup.com (PROC) - Rasio Total Utang marang Ekuitas|Petros Pharmaceuticals, Inc. - Rasio Total Utang marang Ekuitas|Qilian International Holding Group (QLI) - Koefisien Total Utang marang Modal|Total Utang marang Modal ACELYRIN, Inc. SLRN|Utang Agregat marang Ekuitas TFF Pharmaceuticals, Inc